KRT19 and liver cancer: Clinical observations in patients with chronic liver diseases revealed an increased number of CK19+ LPCs with the severity of the diseases 7, 17 Moreover the presence of stemness markers such as CD133 was associated with a poor prognosis and an aggressive tumor behavior of primary liver cancers 29.